Priorities, concerns, and regret among patients with head and neck cancer
Abstract
Background: In the era of deintensification, little data are available regarding patients’ treatment preferences. The current study evaluated treatment‐related priorities, concerns, and regret among patients with head and neck squamous cell cancer (HNSCC). Methods: A total of 150 patients with HNSCC ranked the importance of 10 nononcologic treatment goals relative to the oncologic goals of cure and survival. The level of concern regarding 11 issues and decision regret was recorded. Median rank was reported overall, and factors associated with odds of rank as a top 3 priority were modeled using logistic regression. Results: Among the treatment effects analyzed, the odds of being a top 3 priority was especially high for cure (odds, 9.17; 95% confidence interval [95% CI], 5.05‐16.63), followed by survival and swallow (odds, 1.26 [95% CI, 0.88‐1.80] and odds, 0.85 [95% CI, 0.59‐1.21], respectively). Prioritization of cure, survival, and swallow was similar based on human papillomavirus (HPV) tumor status. By increasing decade of age, older participants were found to be significantly less likely than younger individuals to prioritize survival (odds ratio, 0.72; 95% CI, 0.52‐1.00). Concerns regarding mortality ( P = .04) and transmission of HPV to the patient’s spouse ( P = .03) were more frequent among participants with HPV‐associated HNSCC. Regret increased with additional treatment modalities ( P = .02). Conclusions: Patients with HNSCC overwhelming prioritize cure, followed by survival and swallow. The decreased prioritization of survival by older age supports further examination of treatment preference by age. The precedence of oncologic over nononcologic priorities among patients regardless of HPV tumor status supports the conservative adoption of deintensification regimens until the interplay between competing oncologic and nononcologic treatment goals is better understood.Keywords
Funding Information
- National Institute of Dental and Craniofacial Research (P50 DE019032 and R35DE026631)
- National Institutes of Health (5T32DC000027-29)
This publication has 33 references indexed in Scilit:
- Treatment of Older Patients With Head and Neck Cancer: A ReviewThe Oncologist, 2013
- The Psychosocial Care Needs of Patients with HPV-Related Head and Neck CancerOtolaryngologic Clinics of North America, 2012
- Patient preferences for oropharyngeal cancer treatment de‐escalationHead & Neck, 2012
- Human Papillomavirus–Positive Oral Cavity and Oropharyngeal Cancer Patients Do Not Have Better Quality‐of‐Life TrajectoriesOtolaryngology–Head and Neck Surgery, 2012
- Priorities for the Head and Neck Cancer Patient, their Companion and Members of the Multidisciplinary Team and Decision RegretClinical Oncology, 2011
- Future of Cancer Incidence in the United States: Burdens Upon an Aging, Changing NationJournal of Clinical Oncology, 2009
- Distinct Risk Factor Profiles for Human Papillomavirus Type 16–Positive and Human Papillomavirus Type 16–Negative Head and Neck CancersJNCI: Journal of the National Cancer Institute, 2008
- Incidence Trends for Human Papillomavirus–Related and –Unrelated Oral Squamous Cell Carcinomas in the United StatesJournal of Clinical Oncology, 2008
- Prioritizing treatment outcomes: Head and neck cancer patients versus nonpatientsHead & Neck, 2004
- Validation of a Decision Regret ScaleMedical Decision Making, 2003